UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000017033
Receipt number	R000019752
Scientific Title	A phase II neoadjuvant trial of sequential weekly nab-paclitaxel(nanoparticle albumin-bound paclitaxel) (abraxane) in HER2-negative patients, followed by 5-fluorouracil/ epirubicine/ cyclophosphamide (FEC) in operable breast cancer
Date of disclosure of the study information	2015/04/03
Last modified on	2015/04/03 17:07:36

---